- Home
- FORM vs XENE Comparison
FORM vs XENE Comparison
Compare FORM & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORM
- XENE
- Stock Information
- Founded
- FORM 1993
- XENE 1996
- Country
- FORM United States
- XENE Canada
- Employees
- FORM N/A
- XENE N/A
- Industry
- FORM Semiconductors
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- FORM Technology
- XENE Health Care
- Exchange
- FORM Nasdaq
- XENE Nasdaq
- Market Cap
- FORM 3.0B
- XENE 3.3B
- IPO Year
- FORM N/A
- XENE 2014
- Fundamental
- Price
- FORM $39.39
- XENE $40.30
- Analyst Decision
- FORM Strong Buy
- XENE Strong Buy
- Analyst Count
- FORM 8
- XENE 7
- Target Price
- FORM $56.00
- XENE $56.00
- AVG Volume (30 Days)
- FORM 705.6K
- XENE 405.9K
- Earning Date
- FORM 02-05-2025
- XENE 02-27-2025
- Dividend Yield
- FORM N/A
- XENE N/A
- EPS Growth
- FORM N/A
- XENE N/A
- EPS
- FORM 1.72
- XENE N/A
- Revenue
- FORM $742,279,000.00
- XENE N/A
- Revenue This Year
- FORM $17.59
- XENE N/A
- Revenue Next Year
- FORM $8.82
- XENE $1,600.08
- P/E Ratio
- FORM $22.98
- XENE N/A
- Revenue Growth
- FORM 12.31
- XENE N/A
- 52 Week Low
- FORM $37.25
- XENE $35.53
- 52 Week High
- FORM $63.63
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- FORM 40.27
- XENE 53.03
- Support Level
- FORM $38.28
- XENE $39.25
- Resistance Level
- FORM $41.57
- XENE $41.40
- Average True Range (ATR)
- FORM 1.58
- XENE 1.26
- MACD
- FORM -0.34
- XENE 0.11
- Stochastic Oscillator
- FORM 29.53
- XENE 66.46
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc designs, develops, manufactures, sells, and supports semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.